Inhibition of type I and III IP3Rs by TGF-β is associated with impaired calcium release in mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 278, Issue 6 47-6, 2000, Pages

  Sharma, Kumar ^a   Mc Gowan, Tracy A ^a   Wang, Lewei ^a   Madesh, Muniswamy ^a   Kaspar, Vince ^a   Szalai, Gabor ^a   Thomas, Andrew P ^a   Hajnóczky, György ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Calcium mobilization; Inositol 1,4,5 trisphosphate receptors; Mesangial cells; Transforming growth factor 1

Indexed keywords

CALCIUM; EPIDERMAL GROWTH FACTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELLULAR DISTRIBUTION; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION;

EID: 0033921930     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.278.6.f1022     Document Type: Article

References (39)

1. Aleveizopoulos A, Dusserre Y, Ruegg U, and Mermod N. Regulation of the transforming growth factor b-responsive transcription factor CTF-1 by calcineurin and calcium/calmodulin-de pendent kinase IV. J Biol Chem 272: 23597-23605, 1997.
2. 2+ mobilization. Biochem Biophys Res Commun 210: 378-383,1995.
3. 2+. Biochem J 326: 215-220, 1997.
4. Berridge MJ. Inositol trisphosphate and calcium signaling. Nature 361: 315-325, 1993.
5. 2+ release induced by myo-inositol trisphosphate and the implication in signal transduction. In: Subcellular Biochemistry, edited by Missiaen L, Parys J, De Smedt H, Sienaert I, Bootman M, and Casteels R. New York: Plenum, 59-95, 1996.
6. Bokkala S and Joseph S. Angiotensin II-induced downregulation of inositol trisphosphate receptors in WB rat liver epithelial cells. J Biol Chem 272: 12454-12461, 1997.
7. Csordas G, Thomas A, and Hajnoczky G. Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria. EMBO J 18: 96-108, 1999.
8. Dolmetsch R, Xu K, and Lewis R. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392: 933-936, 1998.
9. Fukui M, Nakamura T, Ebihara I, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, and Koide H. Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med 122: 149-156, 1993.
10. Grasso P, Reichert LJ, Sporn M, and Santa-Coloma T. Transforming growth factor-beta 1 modulates calcium metabolism in Sertoli cells. Endocrinology 132: 1745-1749, 1993.
11. 2+ mobilization in permeabilized hepatocytes. Biochem J 293: 413-422, 1993.
12. 3 receptor. EMBO J 16: 3533-3543, 1997.
13. Hostetter T. Pathogenesis of diabetic nephropathy. In: The Progressive Nature of Renal Disease, edited by Mitch W. New York, Churchill Livingstone, 1986, vol. 14, p.149-166 (Contemp Iss Nephrol).
14. Hostetter TH, Troy JL, and Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415, 1981.
15. Joseph S and Ryan SV. Phosphorylation of the inositol triphosphate receptor in isolated rat hepatocytes. J Biol Chem 268: 23059-23065, 1993.
16. Joseph SK. Biosynthesis of the inositol trisphosphate receptor in WB rat liver epithelial cells. J Biol Chem 269: 5673-5679, 1994.
17. Khan AA, Soloski MJ, Sharp AH, Schilling G, Sabatinin DM, Li SH, Ross CA, and Snyder SH. Lymphocyte apoptosis: Mediation by increased type 3 inositol 1,4,5-triphosphate receptor. Science 273: 503-507, 1996.
18. 2+ spike frequency can optimize gene expression. Nature 392: 936-941, 1998.
19. Maryleitner M, Schafer R, and Fleisher S. IP3 receptor purified from liver plasma membrane is an (1,4,5)IP3 activated and (1,3,4,5)IP4 inhibited calcium permeable ion channel. Cell Calcium 17: 141-153, 1995.
20. Monkawa T, Hayashi M, Miyawaki A, Sugiyama T, Yamamomoto-Hino M, Hasegawa M, Furuichi T, Mikoshiba K, and Saruta T. Localization of inositol 1,4,5-trisphosphate receptors in the rat kidney. Kidney Int 53: 296-301, 1998.
21. Muallem S, Pandol S, and Beeker T. Hormone-evoked calcium release from intracellular stores is a quantal process. J Biol Chem 264: 205-212, 1989.
22. Muldoon LL, Rodland KD, and Magun BE. Transforming growth factor-β and epidermal growth factor alter calcium influx and phosphatidylinositol turnover in rat-1 fibroblasts. J Biol Chem 263: 18834-18841, 1988.
23. Nakamura T, Ebihara I, Fukui M, Osada S, Nagaoka I, Horikoshi S, Tomino Y, and Koide H. Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis. Clin Immunol Immunopathol 66: 33-42, 1993.
24. Osterby R. The number of glomerular cells and substructures in early juvenile diabetes. Acta Pathol Microbiol Scand Sect A Pathol 80: 785-800, 1972.
25. Osterby R. Early phases in the development of diabetic glomerulopathy. A quantitative electron microscopic study. Acta Med Scand 574(suppl): 1-82, 1974.
26. 3 and dissociation from calcium release. Cell 89: 973-980, 1997.
27. Sharma K, Guo J, Jin Y, and Ziyadeh FN. Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996.
28. Sharma K, Wang L, Zhu Y, Bokkala S, and Joseph S. Transforming growth factor-b1 inhibits type I inositol 1,4,5-trisphosphate receptor expression and enhances its phosphorylation in mesangial cells. J Biol Chem 272: 14617-14623, 1997.
29. Sharma K and Ziyadeh FN. Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-β as a key mediator. Diabetes 44: 1139-1146, 1995.
30. I MF-2 smooth muscle cells. Cell Calcium 23: 11-21, 1998.
31. Sugiyama T, Furuya A, Monkawa T, Yamamoto-Hino M, Satoh S, Ohmori K, Miyawaki A, Hanai N, Mikoshiba K, and Hasegawa M. Monoclonal antibodies distinctively recognizing the subtypes of inositol 1,4,5-trisphosphate receptor: application to the studies on inflammatory cells. FEBS Lett 354, 1994.
32. 2 in osteoblasts. J Biol Chem 271: 21835-21841, 1996.
33. 2+ binding proteins in RBL-2H3 rat basphilic leukemia cells. Cell Calcium 22:475-486, 1997.
34. Wahl M, Jones G, Nishibe S, Rhee S, and Carpenter G. Growth factor stimulation of phosphlipase C-gamma 1 activity: comparative properties of control and activated enzymes. J Biol Chem 267: 10447-10456, 1992.
35. Wojcikiewicz RH, Furuichi T, Nakade S, Mikoshiba K, and Nahoski SR. Muscarinic receptor activation downregulates the type I inositol 1,4,5-triphosphate receptor by accelerating its degradation. J Biol Chem 269: 7963-7969, 1994.
36. Wojcikiewicz RH and Nahoski SR. Chronic muscarinic stimulation of SH-SY5Y neuroblastoma cells suppresses inositol 1,4,5-triphosphate action. J Biol Chem 266: 22234-22241, 1991.
37. Wolf G, Haberstroh U, and Neilson EG. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140: 95-107, 1992.
38. Yang T, Terada Y, Nonuguchi H, Tomita K, and Marumo F. Expression of mRNAs for different types of IPS receptors in rat kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1046-F1052, 1995.
39. Zhu Z, Tepel M, Neusser M, and Zidek W. Transforming growth factor beta 1 modulates angiotensin II-induced calcium influx in vascular smooth muscle. Eur J Clin Invest 25: 317-321, 1995.